666 related articles for article (PubMed ID: 15381597)
1. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
[TBL] [Abstract][Full Text] [Related]
2. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
[TBL] [Abstract][Full Text] [Related]
3. Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors.
Gallo A; Manciocco V; Simonelli M; Pagliuca G; D'Arcangelo E; de Vincentiis M
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):620-5. PubMed ID: 16027286
[TBL] [Abstract][Full Text] [Related]
4. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
[TBL] [Abstract][Full Text] [Related]
5. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
6. Local recurrence after vertical partial laryngectomy, a conservative modality of treatment for patients with Stage I-II squamous cell carcinoma of the glottis.
Laccourreye O; Gutierrez-Fonseca R; Garcia D; Hans S; Hacquart N; Ménard M; Brasnu D
Cancer; 1999 Jun; 85(12):2549-56. PubMed ID: 10375101
[TBL] [Abstract][Full Text] [Related]
7. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
8. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of 57 patients with poorly differentiated carcinomas of the supraglottic larynx].
Liu WS; Tang PZ; Qi YF; Xu ZG; Li ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Sep; 39(9):562-5. PubMed ID: 15606009
[TBL] [Abstract][Full Text] [Related]
10. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
[TBL] [Abstract][Full Text] [Related]
11. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: II. An analysis of the incidence, related variables, and consequences of local recurrence.
Laccourreye O; Hans S; Ménard M; Garcia D; Brasnu D; Holsinger FC
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):592-9. PubMed ID: 16027281
[TBL] [Abstract][Full Text] [Related]
12. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
13. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
[TBL] [Abstract][Full Text] [Related]
14. A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis.
Laccourreye O; Diaz EM; Bassot V; Muscatello L; Garcia D; Brasnu D
Cancer; 1999 Jan; 85(1):40-6. PubMed ID: 9921972
[TBL] [Abstract][Full Text] [Related]
15. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of resection margins in supracricoid laryngectomy.
Gallo A; Manciocco V; Tropiano ML; Simonelli M; Marvaso V; D'Arcangelo E; de Vincentiis M
Laryngoscope; 2004 Apr; 114(4):616-21. PubMed ID: 15064613
[TBL] [Abstract][Full Text] [Related]
17. Supracricoid partial laryngectomy: an alternative to total laryngectomy for locally advanced laryngeal cancers.
Soudry E; Marmor Y; Hazan A; Marx S; Sadov R; Feinmesser R
J Laryngol Otol; 2008 Nov; 122(11):1219-23. PubMed ID: 18534043
[TBL] [Abstract][Full Text] [Related]
18. Supracricoid partial laryngectomy with cricohyoidopexy and cricohyoidoepiglottopexy: functional and oncological results.
Karasalihoglu AR; Yagiz R; Tas A; Uzun C; Adali MK; Koten M
J Laryngol Otol; 2004 Sep; 118(9):671-5. PubMed ID: 15509363
[TBL] [Abstract][Full Text] [Related]
19. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
20. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.
Laccourreye O; Brasnu D; Biacabe B; Hans S; Seckin S; Weinstein G
Head Neck; 1998 Oct; 20(7):595-9. PubMed ID: 9744458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
